🎉Huge congrats to Kathleen Mills, PhD, on being named a 2025 ICIS Young Investigator Awardee! Her success reflects the drive and excellence we see across our IMP students! You've done amazing work in the Hohl lab.👏We wish you the best, onward and upward! signals.cytokinesociety.org/2025/07/14/2...

So happy to see this story come together. Check it out! Kathleen Mills and many collaborators - GM-CSF–mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus | Science Immunology www.science.org/doi/10.1126/...

We don't spend a penny on marketing. It's all word of mouth for @costplusdrugs.com That's how we keep prices so low. Please spread the word !

Out today in @naturegenet.bsky.social -- PERFF-seq! With @tsionabay.bsky.social , @ronanchaligne.bsky.social, Bob Stickels, Meril Takizawa, + Ansu Satpathy, we describe this new assay to study rare populations with programmable nucleic acid cytometry. 1/n www.nature.com/articles/s41...

Due to the current issues with funding a congressional continuing resolution, the Accelerating Kids’ Access to Health Care Act may fail. Please take 1-2 minutes now and click this link to send messages to your representatives. @astct.bsky.social #Cancer #HealthCare takeaction.io/astct/urge-l...

Poster bananza from our MsK experts tonight ⬇️. #ASH24

Telehealth Will Die In 3 Weeks Without Congressional Action www.forbes.com/sites/judyst...

A throwback poster from last night at @ash-hematology.bsky.social: Dr. Danny Luan, a fellow in the the MSK Precision Cellular Therapy Laboratory, shared research on "Patterns of Immune Reconstitution and Their Clinical Significance in Aggressive Lymphoma Treated with CAR-T Therapy.” #ASH24

Some highlights from my talk on Allo-HCT for #Hodgkin #lymphoma #ASH24 - Summary: utilization has decreased in the era of novel therapies (BV, CPI) but outcomes have improved dramatically. Joint @cibmtr.bsky.social EBMT analysis showed improved PFS but = OS in AlloHCT recipients with prior CPI 1/n

Great work by 2 talented junior investigators. Danny Luan described immune recovery post #CARTcells (paper accepted this week!) & Marina Gomez performed dynamic landmark analysis post CD19 CAR-T #ash24 #lymsm

Looking forward to this talk by @mskcancercenter.bsky.social Susan Dewolf #637 Cross-Talk between Leukemic Blasts and T Cells Drives Targetable T Cell Dysfunction in the AML Tumor Microenvironment Session: 618. AML: Biomarkers Sunday, Dec 8: 4:30 PM #ASH24 #leusm ash.confex.com/ash/2024/web...

Kai has 2 talks at #ASH24 2nd one on predicting toxicity & response before apheresis in BCMA #CARTcells recipients with RRMM? #mmsm 👉 Utility of the CAR HEMATOTOX for early tox prediction 👉 Identification of ultra high risk pts (1 yr PFS 20%) when combining with MM specific RF

Come and check out @mskcancercenter.bsky.social Kai Rejeski's talk on #CARTcells toxicity #ASH24 👉 In CAR-TOGRAPHY we graded >32,500 pt days across 4 sites in 902 CAR-T recipients, yielding >125,000 unique toxicity datapoints. 👉 Develop new metrics to describe early toxicity: CTI & tox phenotypes

More #ASHThrowback from #ASH22 @mskcancercenter.bsky.social alumni Marco Davila & Marcela Maus, Colleagues Roni Shouval & @ssraj017.bsky.social former MSK visiting investigator now at @vhio.bsky.social Pere Barba & amazing #ASTCT team #ASH24 #ASHconnections #hemesky #bmtsm #CARTcells